Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
- PMID: 28604730
- PMCID: PMC5510465
- DOI: 10.1038/ng.3892
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
Abstract
Although several lung cancer susceptibility loci have been identified, much of the heritability for lung cancer remains unexplained. Here 14,803 cases and 12,262 controls of European descent were genotyped on the OncoArray and combined with existing data for an aggregated genome-wide association study (GWAS) analysis of lung cancer in 29,266 cases and 56,450 controls. We identified 18 susceptibility loci achieving genome-wide significance, including 10 new loci. The new loci highlight the striking heterogeneity in genetic susceptibility across the histological subtypes of lung cancer, with four loci associated with lung cancer overall and six loci associated with lung adenocarcinoma. Gene expression quantitative trait locus (eQTL) analysis in 1,425 normal lung tissue samples highlights RNASET2, SECISBP2L and NRG1 as candidate genes. Other loci include genes such as a cholinergic nicotinic receptor, CHRNA2, and the telomere-related genes OFBC1 and RTEL1. Further exploration of the target genes will continue to provide new insights into the etiology of lung cancer.
Figures



Similar articles
-
Transcriptome-wide association study reveals candidate causal genes for lung cancer.Int J Cancer. 2020 Apr 1;146(7):1862-1878. doi: 10.1002/ijc.32771. Epub 2019 Dec 9. Int J Cancer. 2020. PMID: 31696517 Free PMC article.
-
Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.Lung Cancer. 2016 Aug;98:33-42. doi: 10.1016/j.lungcan.2016.05.008. Epub 2016 May 13. Lung Cancer. 2016. PMID: 27393504 Free PMC article.
-
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.J Natl Cancer Inst. 2010 Jul 7;102(13):959-71. doi: 10.1093/jnci/djq178. Epub 2010 Jun 14. J Natl Cancer Inst. 2010. PMID: 20548021 Free PMC article.
-
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.Am J Hum Genet. 2009 Nov;85(5):679-91. doi: 10.1016/j.ajhg.2009.09.012. Epub 2009 Oct 15. Am J Hum Genet. 2009. PMID: 19836008 Free PMC article.
-
Genetic basis for susceptibility to lung cancer: Recent progress and future directions.Adv Cancer Res. 2010;109:51-72. doi: 10.1016/B978-0-12-380890-5.00002-8. Adv Cancer Res. 2010. PMID: 21070914 Review.
Cited by
-
A comprehensive analysis of clinical and polygenic germline influences on somatic mutational burden.Am J Hum Genet. 2024 Feb 1;111(2):242-258. doi: 10.1016/j.ajhg.2023.12.010. Epub 2024 Jan 10. Am J Hum Genet. 2024. PMID: 38211585 Free PMC article.
-
Proteome-wide Mendelian randomization identifies causal plasma proteins in lung cancer.iScience. 2024 Jan 20;27(2):108985. doi: 10.1016/j.isci.2024.108985. eCollection 2024 Feb 16. iScience. 2024. PMID: 38333712 Free PMC article.
-
Sbp2l contributes to oligodendrocyte maturation through translational control in Tcf7l2 signaling.iScience. 2023 Nov 16;26(12):108451. doi: 10.1016/j.isci.2023.108451. eCollection 2023 Dec 15. iScience. 2023. PMID: 38213786 Free PMC article.
-
Physical Activity Does Not Lower the Risk of Lung Cancer.Cancer Res. 2020 Sep 1;80(17):3765-3769. doi: 10.1158/0008-5472.CAN-20-1127. Epub 2020 Jul 9. Cancer Res. 2020. PMID: 32646967 Free PMC article.
-
Causal association between immune cells and lung cancer risk: a two-sample bidirectional Mendelian randomization analysis.Front Immunol. 2024 Jun 19;15:1433299. doi: 10.3389/fimmu.2024.1433299. eCollection 2024. Front Immunol. 2024. PMID: 38962009 Free PMC article.
References
-
- Ferlay J, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer; Lyon, France: 2013.
Publication types
MeSH terms
Grants and funding
- U19 CA148127/CA/NCI NIH HHS/United States
- R35 CA197449/CA/NCI NIH HHS/United States
- 20622/CRUK_/Cancer Research UK/United Kingdom
- MR/N011317/1/MRC_/Medical Research Council/United Kingdom
- K07 CA172294/CA/NCI NIH HHS/United States
- P50 CA119997/CA/NCI NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- P30 CA076292/CA/NCI NIH HHS/United States
- G0902313/MRC_/Medical Research Council/United Kingdom
- R01 CA151989/CA/NCI NIH HHS/United States
- 202849/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- UM1 CA167462/CA/NCI NIH HHS/United States
- P30 CA071789/CA/NCI NIH HHS/United States
- R01 DA035825/DA/NIDA NIH HHS/United States
- 001/WHO_/World Health Organization/International
- U01 CA164973/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases